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Peter C Whybrow1* and Tasha Glenn2It is increasingly evident that physicians should routinely
ask patients with bipolar disorder about the use of diet-
ary supplements. In our recent study of 348 patients
with bipolar disorder, about 3 out of 10 patients used
dietary supplements in addition to prescribed drugs,
with 2 in 10 of these taking supplements for the long
term (Bauer et al. 2015). The patients tried about 40 dif-
ferent supplements, with fish oil, vitamin B preparations,
multivitamins, and melatonin taken most frequently.
Dietary supplements have the potential to interfere with
the treatment of bipolar disorder due to patient miscon-
ceptions, and the safety and quality of some products.
Patients may turn to dietary supplements to counter-
act side effects of prescribed drugs or because of a poor
outcome. The majority of dietary supplements are self-
selected, rather than recommended by a physician, and
product choice is primarily influenced by friends, testi-
monials, aggressive marketing claims, price, and tradi-
tions (OIG 2012; New York State 2005). Many patients
have misconceptions about dietary supplements, such as
that “natural” is synonymous for safe, that supplements
are safer than prescribed drugs, that megadoses are safe,
and that the products and advertisements are pre-
approved by the FDA.
Dietary supplements may interact with prescription
drugs or with other dietary supplements (Izzo and Ernst
2009). Most interactions with dietary supplements re-
ported in the literature involve prescription drugs that
affect the central nervous system or cardiovascular system
(Tsai et al. 2012). Patients with bipolar disorder may also
be at increased risk of interactions because they often take
multiple prescription drugs. Another concern is that some
dietary supplements may potentially cause psychiatric ad-
verse reactions such as anxiety, panic attack, confusion,
hallucinations, or mania (Ernst 2003). The FDA estimates* Correspondence: PWhybrow@mednet.ucla.edu
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medium, provided the original work is properlythat there is extensive underreporting of adverse events
from dietary supplements (GAO 2013).
Many quality problems have been reported for dietary
supplements, including product contamination, ingredi-
ents not matching those listed on the label, and dosage
strength inconsistencies. Between 2004 and 2012, of all
FDA drug recalls due to risk of serious adverse conse-
quences or death, over half were for dietary supplements
(Harel et al. 2013). Analytical testing of the ingredients
in many dietary supplements manufactured in the US
found the strength varied widely from that listed on the
label (Lockwood 2011). In 2015, an investigation by the
New York State Attorney General’s office found that
80 % of store brand herbal dietary supplements at 4
large national chain stores did not contain the herbs
listed on the label (O’Connor 2015). In addition, en-
forcement of current good manufacturing practices by
the FDA is limited, with only 11 % of the dietary supple-
ment manufacturing facilities inspected in fiscal year
2013 (Long 2014).
The evidence suggests that physicians should assume
that patients will not volunteer information on the use
of supplements and that this may not be included in a
patient's electronic medical record. To provide optimal
treatment of bipolar disorder, physicians need to under-
stand patient use of dietary supplements.
Author details
1Department of Psychiatry and Biobehavioral Sciences, Semel Institute for
Neuroscience and Human Behavior, University of California Los Angeles
(UCLA), 300 UCLA Medical Plaza, Los Angeles, CA 90095, USA. 2ChronoRecord
Association Inc., PO Box 3501, Fullerton, CA 92834, USA.
Received: 11 June 2015 Accepted: 12 June 2015
References
Bauer M, Glenn T, Conell J, Rasgon N, Marsh W, Sagduyu K, Munoz R, Lewitzka U,
Bauer R, Pilhatsch M, Monteith S, Whybrow PC. Common use of dietary
supplements for bipolar disorder: a naturalistic, self-reported study.
Int J Bipolar Disord. 2015;3(1):29.
Ernst E. Serious psychiatric and neurological adverse effects of herbal medicines—a
systematic review. Acta Psychiatr Scand. 2003;108:83–91.ccess article distributed under the terms of the Creative Commons Attribution
y/4.0), which permits unrestricted use, distribution, and reproduction in any
credited.
Whybrow and Glenn International Journal of Bipolar Disorders  (2015) 3:19 Page 2 of 2GAO (US Government Accountability Office). Dietary supplements: FDA may have
opportunities to expand its use of reported health problems to oversee
products. GAO-13-244. 2013. http://www.gao.gov/products/GAO-13-244
Accessed March 9, 2015.
Harel Z, Harel S, Wald R, Mamdani M, Bell CM. The frequency and characteristics
of dietary supplement recalls in the United States. JAMA Intern Med.
2013;173:926–8.
Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an
updated systematic review. Drugs. 2009;69:1777–98.
Lockwood GB. The quality of commercially available nutraceutical supplements
and food sources. J Pharm Pharmacol. 2011;63:3–10.
Long J. FDA data: supplement cGMP compliance rates show modest improvement.
2014. http://www.naturalproductsinsider.com/news/2014/02/fda-data-
supplement-cgmp-compliance-rates-show-mo.aspx Accessed March 9, 2015.
New York State Task Force on Life & the Law, New York State Department of
Health. Dietary supplements: balancing consumer choice and safety. 2005.
http://www.health.ny.gov/regulations/task_force/docs/dietary_supplement_
safety.pdf Accessed March 9, 2015.
O’Connor A. New York attorney general targets supplements at major retailers.
http://well.blogs.nytimes.com/2015/02/03/new-york-attorney-general-
targets-supplements-at-major-retailers/?_r=0 New York Times. Accessed
March 9, 2015.
OIG (US Office of the Inspector General). Dietary supplements: structure/function
claims fail to meet federal requirements. 2012 Report (OEI-01-11-00210)
https://oig.hhs.gov/oei/reports/oei-01-11-00210.asp Accessed March 9, 2015.
Tsai HH, Lin HW, Simon Pickard A, Tsai HY, Mahady GB. Evaluation of
documented drug interactions and contraindications associated with herbs
and dietary supplements: a systematic literature review. Int J Clin Pract.
2012;66:1056–78.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
